Related Experiment Videos
[Diabetes mellitus as a risk factor for arteriosclerosis]
1Second Department of Internal Medicine, Kobe University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1993
Summary
Diabetes mellitus significantly increases risks for heart and brain diseases, especially when combined with high cholesterol. Even without high cholesterol, diabetics show abnormal lipoprotein metabolism, promoting arteriosclerosis.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Metabolic Disorders
Context:
- Diabetes mellitus is a significant risk factor for coronary heart disease and cerebrovascular disease.
- Diabetic patients frequently exhibit hyperlipidemia, with approximately 70% showing dyslipidemia, increasing complication risks.
- Lipoprotein metabolism abnormalities, promoting arteriosclerosis, are present even in normolipidemic diabetics.
Purpose:
- To review the various factors contributing to arteriosclerosis in diabetic patients.
- To highlight abnormal lipoprotein metabolism as a key factor in diabetic cardiovascular complications.
- To discuss specific atherogenic lipoproteins and other contributing factors in diabetes.
Summary:
- Diabetes mellitus elevates risks for cardiovascular and cerebrovascular diseases, exacerbated by frequent hyperlipidemia and dyslipidemia.
- Abnormalities in lipoprotein metabolism, including increased cholesterol in intermediate-density lipoproteins and the presence of glycated-LDL and small, dense LDL, are key contributors to arteriosclerosis in diabetics.
- Other factors like elevated lipoprotein (a), hyperinsulinemia, enhanced polyol pathway, and platelet dysfunction also promote arteriosclerosis in diabetic individuals.
Impact:
- Understanding these factors can lead to targeted interventions for preventing cardiovascular complications in diabetic patients.
- This review emphasizes the critical role of lipoprotein metabolism in diabetic arteriosclerosis, guiding future research and clinical practice.
- Identifying and managing dyslipidemia and other atherogenic factors in diabetics is crucial for reducing long-term morbidity and mortality.